Winston Kung's Net Worth
$918 Thousand
Who is Winston Kung?
Winston Kung does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PMV Pharmaceuticals, Inc., Alliqua BioMedical, Inc., Janux Therapeutics, Inc., ArriVent Biopharma, Inc., and Corbus Pharmaceuticals Holdings, Inc..
SEC CIK
Winston Kung's CIK is 0001666963
Past Insider Trading and Trends
2021 was Winston Kung's most active year for acquiring shares with 6 total transactions. Winston Kung's most active month to acquire stocks was the month of May. 2021 was Winston Kung's most active year for disposing of shares, totalling 10 transactions. Winston Kung's most active month to dispose stocks was the month of July. 2021 saw Winston Kung paying a total of $74,060.00 for 73,337 shares, this is the most they've acquired in one year. In 2021 Winston Kung cashed out on 43,725 shares for a total of $607,802.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.6588
COO, CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| -19.45% | -2.56K |
—
|
—
| 10.6K |
Nov 25
| |||
Form 4
| +60.61% | 4K |
$3.22 | $12,880.00 | 10.6K |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -29.22% | -2.73K |
—
|
—
| 6.6K |
Dec 30
| |||
Form 4
| +312.50% | 5K |
$3.22 | $16,100.00 | 6.6K |
Aug 19
| |||
Form 4
|
—
|
0
|
$18.52 | -$137,687.85 | 1.6K |
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$18.49 | -$137,385.00 | 1.6K |
Scheduled
|
Jul 8
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
$18.49 | -$137,385.00 | 1.6K |
Scheduled
|
Jun 4
| ||
Form 4
|
—
|
0
|
$18.49 | -$137,385.00 | 1.6K |
Scheduled
|
May 3
| ||
Form 4
|
∞
| 1.6K |
$3.22 | $5,152.00 | 1.6K |
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alliqua BioMedical, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Janux Therapeutics, Inc. (JANX) Snapshot price: $42.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.5K |
—
|
—
| 2.5K |
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ArriVent Biopharma, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Snapshot price: $50.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.57K |
—
|
—
| 5.57K |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||